SpiroChem is pleased to announce its participation in EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026, taking place in Dublin, Ireland from June 22–25, 2026.

This joint symposium on medicinal chemistry will bring together scientists working across medicinal chemistry, drug discovery and molecular sciences in an international setting focused on scientific exchange and current advances in the field.

The conference will be held at Trinity College Dublin, Ireland’s oldest university, which is internationally recognized for excellence in research and education, particularly in the biomedical and chemical sciences. Its School of Chemistry and associated research centers contribute significantly to advances in medicinal chemistry, drug discovery and molecular sciences.

Meet our team on-site:

Gerhard Müller, PhD – Chief Scientific Officer
Quentin Lefebvre, PhD – R&D Leader
Cédric Fries – Business Development Manager

Quentin Lefebvre, PhD, will give a talk on June 23 at 3:00 PM: “Aliphatic C-H Functionalization to Rapidly Access Non-Canonical Amino Acid Building Blocks”

Join us in Dublin to connect with our team and discuss how SpiroChem’s expertise in medicinal chemistry, synthetic chemistry and non-canonical amino acid building blocks can support your discovery programs.

We look forward to engaging with the medicinal chemistry community and discussing new opportunities for collaboration.